NABUMETONE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 12 adverse event reports in the FDA FAERS database where NABUMETONE was used for Psoriasis.
Most Reported Side Effects for NABUMETONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 214 | 27.5% | 0 | 1 |
| Drug ineffective | 74 | 9.5% | 0 | 7 |
| Completed suicide | 48 | 6.2% | 48 | 11 |
| Acute kidney injury | 39 | 5.0% | 2 | 24 |
| Toxicity to various agents | 33 | 4.2% | 24 | 15 |
| Dizziness | 29 | 3.7% | 0 | 12 |
| Pain | 26 | 3.3% | 0 | 8 |
| Headache | 25 | 3.2% | 0 | 8 |
| Nausea | 25 | 3.2% | 0 | 7 |
| Pruritus | 25 | 3.2% | 0 | 6 |
| Rash | 25 | 3.2% | 0 | 1 |
| Cardio-respiratory arrest | 23 | 3.0% | 23 | 6 |
| Arthralgia | 22 | 2.8% | 0 | 4 |
| Product use in unapproved indication | 22 | 2.8% | 1 | 1 |
| Back pain | 21 | 2.7% | 0 | 5 |
Other Indications for NABUMETONE
Product used for unknown indication (237)
Osteoarthritis (46)
Arthralgia (34)
Pain (31)
Arthritis (26)
Rheumatoid arthritis (23)
Psoriatic arthropathy (10)
Neck pain (9)
Back pain (7)
Fibromyalgia (7)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)